Serveur d'exploration H2N2 - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Cross Reactions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cross Protection < Cross Reactions < Crosses, Genetic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000018 (2000) H. Masaki [Japon] ; M. Tamura ; I. KuraneInduction of cytotoxic T lymphocytes of heterogeneous specificities by immunization with a single peptide derived from influenza A virus.
000142 (2006) Edwin D. KilbourneInfluenza immunity: new insights from old studies.
000143 (2006) Suzanne L. Epstein [États-Unis]Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
000192 (2006) J A Desheva [Russie] ; X H Lu ; A R Rekstin ; L G Rudenko ; D E Swayne ; N J Cox ; J M Katz ; A I KlimovCharacterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
000240 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
000263 (2008) Michelle Roti [États-Unis] ; Junbao Yang ; Deanna Berger ; Laurie Huston ; Eddie A. James ; William W. KwokHealthy human subjects have CD4+ T cells directed against H5N1 influenza virus.
000352 (2009) Reiko Yoshida [Japon] ; Manabu Igarashi ; Hiroichi Ozaki ; Noriko Kishida ; Daisuke Tomabechi ; Hiroshi Kida ; Kimihito Ito ; Ayato TakadaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
000367 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
000483 (2010) N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. JulkunenHigh frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
000533 (2010) Grace L. Chen ; Elaine W. Lamirande ; Chin-Fen Yang ; Hong Jin ; George Kemble ; Kanta SubbaraoEvaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets▿
000593 (2010) Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis]Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
000682 (2011) Nobuko Ohshima ; Yoshitaka Iba ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu KurosawaNaturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5 ▿§
000777 (2012) Jenny Aurielle B. Babon [États-Unis] ; John Cruz [États-Unis] ; Francis A. Ennis [États-Unis] ; Liusong Yin [États-Unis] ; Masanori Terajima [États-Unis]A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus
000818 (1990) I N Mbawuike [États-Unis] ; H R Six ; T R Cate ; R B CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
000846 (2012) Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto BurioniInfluenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
000891 (2013) Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. WilsonStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
000922 (????) A N Na Khin ; S A Donina ; G D Petukhova ; E M Koren'Kov ; E M Doroshenko ; E P Grigor'Eva ; M A Suvorova ; L G Rudenko[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
000995 (2014) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets
000A68 (2014) Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000B02 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
000B57 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Cross Reactions" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Cross Reactions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cross Reactions
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021